India has taken a significant step towards strengthening poultry disease prevention with the launch of its first indigenous vaccine against the H5N1 bird flu strain in chickens. Union Agriculture and Farmers’ Welfare Minister Shivraj Singh Chouhan dedicated the vaccine to the nation on November 20, 2026, at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, Madhya Pradesh.
Developed by scientists at ICAR-NIHSAD, the inactivated vaccine specifically targets the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus belonging to Clade 2.3.2.1a. According to the Ministry of Agriculture and Farmers’ Welfare, this strain has been responsible for most bird flu outbreaks in chickens in India. The vaccine has been announced at a price of approximately ₹1–2 per dose, with the stated aim of making protection more affordable for poultry farmers, including small-scale producers.
Editorial Insight
Key Highlights
Important points readers should notice.
Issue/Event: Launch of India's first indigenous H5N1 vaccine for chickens.
Location: India.
Authority/Organisation: ICAR-NIHSAD and Ministry of Agriculture and Farmers’ Welfare.
Action Taken: Vaccine dedicated to the nation on November 20, 2026.
Impact: Aims to strengthen poultry disease prevention and reduce potential losses for farmers.
Bird flu outbreaks can cause severe losses in poultry farms through high bird mortality, culling operations and restrictions on the movement and trade of poultry products. The government has reported more than 500 combined H5N1 and H5N8 outbreaks in India since 2006, highlighting the continuing challenge for the country's poultry sector.
The vaccine development is also relevant to animal and public health because H5N1 infections have been detected in species beyond birds, including mammals. The government has highlighted the need to control the virus in poultry to reduce the risk of its spread to other animals and humans.
Alongside the vaccine dedication, the Agriculture Minister announced a proposed ₹300-crore state-of-the-art animal disease research laboratory in Bhopal. The facility is expected to strengthen India's capacity for animal disease research and related scientific work.
Editorial Analysis
Why This Matters
Protection for poultry: H5N1 outbreaks can cause extensive bird deaths and require large-scale containment measures. Affordable pricing: The announced ₹1–2 per dose price could make vaccination more accessible to poultry farmers. Indigenous research: The vaccine demonstrates domestic scientific capacity in animal health research. Economic importance: Better disease prevention could help protect poultry farming, employment and related supply chains. One Health relevance: Controlling bird flu in poultry is important because the virus can also affect other animal species and poses a public health concern.
The vaccine is intended for chickens and should not be confused with a human bird flu vaccine. Details regarding its wider commercial availability, vaccination schedule and rollout across poultry farms will be important to watch.


